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Abstract
Backgrounds: The aim of this study was to describe the clinicopathological characteristics and high-risk human
papillomavirus (HPV) infection status in patients diagnosed with co-existing of adenoid cystic carcinoma (ACC)
and invasive squamous cell carcinoma (SCC) of the uterine cervix.
Methods: Three patients were identified from the pathology databank of Peking Union Medical College Hospital
from year 2000 to 2014. Immunohistochemistry and in situ hybridization (ISH) were employed in this study.
Results: The patients were aged 64, 77 and 63 years (average, 68 years old). All the patients were postmenopausal
women who presented with bloody or watery vaginal discharge. The cervical cytology screening results were all
suspicious for high-grade squamous intraepithelial lesion (HSIL). The subsequent cervical colposcopy biopsies all
showed cervical intraepithelial neoplasia III (CINIII). One patient received only a cervical conization, whereas the
other two patients underwent hysterectomy. The immunohistochemical results showed that the ACC
compartments were positive for CK7 and CD117; the cases of SCC were negative for CK7 and CD117. P63 staining
was strongly positive and diffuse throughout the SCC compartments, whereas only patchy positive areas were
observed in the ACC. MYB exhibited strong nuclear staining in the ACC and SCC compartments but negative
staining in the endocervical gland. In situ hybridization (ISH) signals for high-risk HPV DNA and mRNA were present
in the two compartments of all three patients. The patients had no evidence of disease at an average follow-up
time of 21.6 months.
Conclusion: High-risk HPV was present in both the ACC and SCC compartments in all three patients.
Background
ACC of the uterine cervix was first described by McGee
et al. in 1965 [1], and there have been more than 100
cases documented in the literature, most of which have
been published as case reports. ACC is an uncommon
variant of adenocarcinoma of the uterine cervix and
accounts for only 1 % of all cases of primary cervical
adenocarcinoma [2]. Compared to its counterpart in the
salivary gland, ACC is believed to have a worse progno-
sis in the uterine cervix. ACC is thought to behave more
aggressively than SCC, but because of its rarity, a stand-
ard treatment method has not been established; patients
with ACC receive the same treatment as those with SCC
[3]. ACC has been reported to be associated with intrae-
pithelial neoplasia (CIN), invasive squamous cell carcin-
oma, adenocarcinoma and sarcoma in the uterine cervix
[4], but the relationship between ACC and these tumors
has not been investigated.
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HPV plays an important role in the pathogenesis of
cervical cancer, and the association between HPV and
squamous cell carcinoma or adenocarcinoma has been
well established. Most previous studies have focused on
exploring the relationship between HPV and squamous
intraepithelial neoplasia, squamous cell carcinoma, ade-
nocarcinoma or small cell carcinoma [5, 6]; few have
reported the association between HPV and ACC in the
uterine cervix.
Here, we present 3 cases of co-existing of ACC and
SCC in the uterine cervix and describe the immunohis-
tochemical characteristics and high-risk HPV infection
status based on an analysis of HPV DNA and mRNA
expression by in situ hybridization. To the best of our
knowledge, this is one of the first and largest studies of
its kind to explore the immunophenotypic properties
and HPV status of the cervix.
Methods
Patients’ information
The surgical pathology archives and consultation prac-
tices of Peking Union Medical College Hospital from
year 2000 to 2014 were searched using the terms “ade-
noid cystic carcinoma” and “cervix”. Only 4 cases were
identified, 3 of which were ACC combined with SCC,
and case 1 has been reported previously [7]; the other
case of the 4 was co-existing of ACC and ABC. Clini-
copathological characteristics were collected, including
age, symptoms, tumor size and type, tumor growth pat-
tern, surgery, FIGO stage, therapy and prognosis. This
study was approved by the Institutional Review Board of
Peking Union Medical College Hospital.
Immunohistochemistry
All the immunohistochemical studies were performed on
formalin-fixed, paraffin-embedded tissue sections with a
thickness of 4 μm using standard autostaining protocols
on a Ventana Benchmark XT autostainer (Ventana Med-
ical Systems Inc., Tucson, AZ). For AE1/AE3, Calponin,
CK7 and SMA, the positive signals appeared as tan parti-
cles in the cytoplasm. For CD117, tan granules on the
membrane or in the cytoplasm indicated positive stain-
ing. For P63, P53, TTF-1, MYB and Ki-67, tan particles
in the nucleolus were observed in positive samples. Tan
particles were not detected in the corresponding loca-
tions in negative samples.
Human papillomavirus DNA detection by in situ
hybridization
For the in situ detection of high-risk HPV infection at
the DNA level, biotin-labeled HPV probe solutions
(Leica, Newcastle, UK) were applied to formalin-fixed,
paraffin-embedded tissue sections. The examination was
carried out automatically using the BOND HPV Probe
set that captures HPV subtypes 16, 18, 31, 33 and 51
using the Leica BOND-MAX system (Bond Ready-to-
Use ISH HPV Probe, CAT # PB0829). Cases with brown
punctate and/or diffuse signals in the tumor cell nuclear
or cytoplasm were interpreted as positive.
Human papillomavirus mRNA detection by RNA in situ
hybridization
For the in situ detection of high-risk HPV integration at
the mRNA level, the RNAscope FFPE 2.0 HD detection
kit (Brown) (Advanced Cell Diagnostics, Hayward, CA,
USA) was used according to the manufacturer’s instruc-
tions. Briefly, 2- to 3-mm thick FFPE tissue sections were
deparaffinized, heated, treated with a protease and hy-
bridized with the probe at 40 °C for 2 h (HPV High Risk
7 Pool: 16,18, 31, 33, 35, 52 and 58, CAT # 312351, Probe
Name: Probe - HPV HR7). After washing and amplifi-
cation, target RNA was detected with 3,39-diaminoben-
zidine. Nuclei were counterstained with hematoxylin.
Positive staining was indicated by brown punctate dots in
the cytoplasm.
Results
The patients were 64, 77 and 63 years old (average,
68 years old). All the patients were postmenopausal
women; the first two patients suffered from bloody vagi-
nal discharge, and the other patient visited a doctor be-
cause of watery vaginal discharge. The results of the
cervical ThinPrep cytological test were all suspicious of
high-grade squamous intraepithelial lesion (HSIL). The
cervical examination of two patients revealed exophilic
and polypoid nodules with maximum diameters of 5 and
15 mm; the tumors were hemorrhagic and fragile, and
they bled heavily in response to palpation. The other pa-
tient’s cervical mucosa was smooth with no evidence of
a tumor. The subsequent cervical colposcopy biopsies all
revealed cervical intraepithelial neoplasia III (CINIII)
with no evidence of invasive squamous carcinoma; the
biopsy specimens were too superficial to make a deter-
mination of invasive squamous carcinoma. One of pa-
tients only underwent a cervical conization and received
a final diagnosis of ACC with concurrent invasive SCC.
The surgical margin was positive. Pelvic magnetic re-
sonance imaging and positron emission tomography-
computed tomography (PET-CT) were performed after
surgery, and these examinations revealed no evidence of
residual disease or local metastasis. The patient refused
to undergo any further operations and therefore received
only radiation and chemotherapy. The other two pa-
tients underwent a hysterectomy, and the results showed
that the tumors were confined to the uterus. The mar-
gins were negative. One patient received radiation and
chemotherapy, whereas the other received only radiation
therapy. The patients were all clinical stage I at the time
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of diagnosis, and there was no evidence of recurrence or
metastasis at the follow-ups at 20 or 25 months. The
demographic and clinical characteristics of the patients
and their treatment regimens are presented in Table 1.
The squamous cell carcinoma morphology was demar-
cated from the adenoid cystic carcinoma in the cervix
(Fig. 1a). The invasion depth of the tumor was 10, 11
and 9 mm. The third one showed lymphovascular inva-
sion. The proportions of the SCC compartments in the
three cases were 60, 80 and 80 % (Table 2). Cervical
SCC is thought to originate from intraepithelial neopla-
sia, and all the cases presented with CINIII (Fig. 1b).
Two of the three patients had poorly differentiated
SCC, and the other patient had well differentiated SCC
(Table 2). Unlike SCC which exhibits keratinization, nu-
clear enlargement, cell atypia and a fibroblastic reaction
around the tumor cells, the ACC compartment was char-
acterized by nests of cells surrounded by basement mem-
brane components. The basaloid tumor cells in the ACC
formed a cribriform growth pattern composed of both
ductal and abluminal myoepithelial cells (Fig. 1c). The
basaloid tumor cells had a small to moderate amount of
cytoplasm, and the nuclei were uniform without con-
spicuous nucleoli (Fig. 1d).
The pathological characteristics, immunohistochemical
staining and high-risk HPV detection results are sum-
marized in Table 2. The two tumor compartments in the
3 cases were positive for AE1/AE3, and the ACC com-
partment was positive for CK7 (Fig. 2a) and CD117; the
SCC compartment was negative for CK7 and CD117.
The SCC compartment in all the cases exhibited strong
and diffuse positive staining for P63 (Fig. 2b), whereas
only patchy positive staining was observed in the ACC
compartment; these patches generally appeared in the
peripheral cells (Fig. 2c). In all the cases, SMA was
expressed in the myoepithelial cells in the ACC com-
partment, but not the SCC compartment. MYB nuclear
staining was strong in the ACC and SCC compartments
(Fig. 2d) but was negative in the endocervical gland. P16,
which is thought to be a surrogate marker for the
presence of HPV, exhibited strong, diffuse nuclear and
cytoplasmic reactivity in both the ACC and SCC com-
partments in all 3 cases. HPV DNA in situ hybridization
signals were present in the two compartments of all 3
cases: 1 case showed punctate nuclear staining, whereas
the other two cases exhibited punctate and diffuse nu-
clear staining (Fig. 2e). The same results were obtained
from the HPV mRNA ISH analysis (Fig. 2f ): strong
brown cytoplasmic staining was present in the two com-
partments in all 3 cases. The hybridization signals were
distributed throughout the basaloid and ductal cells in
the ACC as well as in both the surface dysplasia and the
invasive component of the SCC.
Discussion
In this study, we presented three cases of co-existing of
ACC and SCC in the uterine cervix. In the literature re-
view which was presented in Table 3, there were few re-
ports of co-existing of ACC and SCC and scarce data on
the HPV status in these cases. The average age of the
three patients in this study was 68 years, which was con-
sistent with the patients described in the literature (aver-
age, 61.4 years old). The majority of the patients were
postmenopausal women, and the predominant present-
ing symptom was vaginal bleeding, which was the case
in two of our patients. The tumors usually present as a
polypoid or outgrowth mass in the cervix; more ad-
vanced clinical stage (stage II and III) is associated with
early recurrence and metastasis. Including our three
cases, high-risk HPV infection has been identified in 6
of the 8 cases in both the ACC and SCC compartments,
whereas HPV infection was absent in two of the eight
cases in both compartments.
Immunohistochemistry was helpful for distinguishing
SCC from ACC in these cases. P63 is a useful marker
that shows strong and diffuse nuclear staining in SCC
but only peripheral or compartmentalized distribution in
ACC. SCC is negative for CK7 and CD117, but the
luminal component of ACC is positive for CK7 and
CD117. ACC is characterized by the expression of myoe-
pithelial markers, such as SMA, S-100 or calponin and
there was positive SMA staining in the ACC from the
three cases in our study. Recent studies have shown that
a t(6;9)(q22–23;p23–24) translocation that results in a
MYB-NFIB gene fusion is specific for ACC [8, 9]; this
MYB-NFIB fusion contributes to MYB overexpression.





















1 64 5 Polypoid HSIL Conization + I R + C - 20, NED
2 63 10 Invasive HSIL Hysterectomy - I R + C - 25, NED
3 77 15 Polypoid HSIL Hysterectomy - I R - 20, NED
Salpingectomy
Oophorectomy
HSIL high-grade squamous intraepithelial lesion, NA not available, R radiation, C chemotherapy, NED no evidence of disease
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In this study, the ACC in all three cases exhibited strong
nuclear MYB staining, which provided further confirm-
ation of the diagnosis.
The major differentiation of ACC is ABC, which is
also a neoplasia that originates from the salivary gland.
The discrimination of ACC from ABC basically relies on
morphology; ACC exhibits cellular pleomorphism, mi-
toses, necrosis and stromal hyalinization. Besides these
characteristics, ABC is defined based on the absence of
the MYB translocation and CD117 immunostaining. All
of our 3 cases showed CD117 positive staining by IHC,
while in Andrzej Wincewicz’s study, ABC was negative
for CD117 [10]. ACC is thought to be more aggressive
than SCC in the cervix and to have a high potential for
metastasis and recurrence, whereas ABC is considered
to be a neoplasia instead of a carcinoma because of its
indolent character and benign clinical behavior. Lin
reported a case of co-existing of ABC and SCC in the
cervix and concluded that we must avoid overestimating
the clinical stage because ABC is thought to be a benign
lesion [11]. However, ACC is thought to behave more
aggressively than SCC; therefore, the proper identifica-
tion of ACC is important, and an appropriately enhanced
treatment regimen, including post-operative radiation
and chemotherapy, along with careful clinical follow-up
are recommended.
The association between HPV and cervical squamous
cell carcinoma and adenocarcinoma has been well docu-
mented, but few articles have investigated the relation-
ship between HPV and ACC of the cervix. Currently,
over 100 genotypes of HPV have been identified, and
they can be subdivided into three groups: high-risk, low-
risk and unclassified [12]. The high-risk HPV types
include types 16, 18, 31, 33, 35, 45, 51, 52 and 56, and
these types are believed to play a major role in the
pathogenesis of cervical carcinoma. The progression
Fig. 1 a The invasive SCC component of the tumor with keratinization (HE, ×40); b CINIII in the overlaying squamous epithelial (HE, ×40);
c and d The lower power and high power image of ACC component of the tumor (HE, ×40; ×100)






Proportion (%) Depth of
invasion (mm)
LVI CD117 CK7 SMA Calponin P63 MYB P16 DNA mRNA
1 SCC Morderate 60 9 - - - - - D+ + + + +
ACC Cribriform 40 + + + + P+ + + + +
2 SCC Low 80 11 - - - - - D+ + + + +
ACC Cribriform 20 + + + - P+ + + + +
3 SCC Low 80 10 + - - - - D+ + + + +
ACC Cribriform 20 + + + - P+ + + + +
ISH in situ hybrization, LVI lymphovascular invasion, D diffuse, P patchy
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from a premalignant lesion to cervical cancer is primar-
ily caused by high-risk HPV, especially types 16 and 18
[13]. Once HPV integrates into the host genome, the E2
opening read frame (ORF) is deleted, resulting in the
deregulated expression of the viral oncogenes E6 and E7;
these two oncogenes interfere with critical cell cycle
pathways (p53 and RB) and increase cell proliferation
[12, 14]. P16 is considered to be a surrogate detection
marker for HPV infection in the cervix. P16 is negatively
regulated by Rb, and it is therefore over-expressed in
cervical carcinoma cells in which Rb is inactivated by
HPV E7. There are several methods for detecting HPV
status, for example, non-isotopic in situ hybridization
(NISH) and PCR; NISH can identify both episomal and
integrated HPV in archival cervical biopsy material with
a sensitivity of 2.5-20 viral copies per cell. The NISH
signal pattern was analyzed using the criteria established
by Cooper et al. There are three types of signals: type 1
(diffuse), indicative of episomal HPV DNA; type 2 (punc-
tate); and type 3 (a combination of punctate and diffuse),
indicative of integrated HPV DNA. In our study, one of
the three cases showed a type 2 signal, and the other two
showed type 2 and 3 signals, which was indicative of
HPV integration into the host genome in both the SCC
and ACC compartments. mRNA ISH is emerging as a
promising method for detecting HPV infection based on
the mRNA levels in archival materials; this method not
only analyzes the signal in situ but also determines the
status of E6/E7, which are thought to be vital for the
pathogenesis of cervical cancer, with high sensitivity. In
our three cases, both the SCC and ACC compartments
were positive based on the NISH results.
The origination of ACC in the cervix remains uncertain,
but some immunohistochemical evidence has shown that
this lesion may originate from the reserve cell layer of the
cervical epithelium [4]. The reserve cells lie beneath the
columnar mucinous epithelial cells of the endocervix and
are considered to have the ability to generate both the
squamous and glandular epithelium. To the best of our
knowledge, the histogenesis of concurrent ACC and SCC
has not yet been studied, and whether they undergo poly-
clonal origination to form a merged tumor or they are
monoclonal in origin, sharing a common stem cell, needs
to be explored further. HPV is reported to be an early
event that is detected not only in invasive carcinoma but
also in intraepithelial neoplasia [15]. In our study, it was
demonstrated that the integration of high-risk HPV and
the up-regulation of the viral oncogenes E6/E7 occurred
in the ACC, SCC and CIN. These data may suggest
that these diseases are of monoclonal origin and that
the divergence occurs late in the tumorigenic process.
Conclusion
We present three cases of co-existing of ACC and
SCC in the uterine cervix. High-risk HPV was de-
tected in both the ACC and SCC in all three cases.
Fig. 2 a CK7 immunostain is positive in the ACC component (CK7, ×40); b P63 immunostain is patchy positive in the ACC component (P63, ×40);
c P63 immunostain is diffuse positive in the SCC component (P63, ×40); d C-MYB immunostain is positive in the ACC component (C-MYB, ×40);
e HPV detected by DNA ISH method is punctate positive in the ACC component (HPV ISH, ×100); f HPV detected by mRNA ISH method is positive in
the ACC component (HPV ISH, ×100)
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Table 3 Summary of reported cases of cervical adenoid cystic carcinoma coexisting with invasive squamous cell carcinoma
Author Age Symptom Tumor type/size Clinical stage HPV result Microscopic appearance Treatment method Status(duration of survival)
Grayson, W et al. [16] 68 NA NA NA HPV16 in both ACC + SCC + CIS + sarcoma NA NA
55 NA NA NA HPV16 in both ACC + SCC + CIS + focal ABC + sarcoma NA NA
36 NA NA NA Neg ACC + SCC + sarcoma NA NA
Yang, Y. J et al. [17] 36 NA No gross nodular NA Neg ACC + SCC + CIS + condyloma Surgery No
Grayson, W et al. [18] NA NA NA NA HPV16 in both ACC + superficially invasive SCC NA NA
Seth, A et al. [19] 24 Bleeding Exophytic/3 cm NA NA ACC + focal SCC Surgery NA
Grayson, W et al. [4] NA NA NA NA NA 6 of 18 ACC showed ACC + invasive SCC,
1 case showed ACC + invasive SCC + ABC
NA NA
Mathoulin-Portier,
M. P et al. [20]
73 Bleeding Necrotic mass/5 cm NA NA ACC+ a RARE focal SCC + sarcoma Surgery Metastasis 12 months later,
Live with disease 36 months
Manhoff, D. T et al. [21] 80 Bleeding Protruded mass/NA NA NA ACC + focally invasive SCC+ malignant stroma Surgery + Radiation NED, 6 months
Albores-Saavedra et al. [22] NA NA NA NA NA 3 of 7 patients showed ACC + focal invasive SCC NA NA
Ferry, J. A et al. [23] NA NA NA NA NA 1 of 14 patients showed ACC + SCC + CIS + ABC NA NA
Musa, A. G et al. [24] NA NA NA NA NA 2 of 17 patients showed ACC + invasive SCC NA NA
Berchuck, A et al. [25] 72 Bleeding Exophytic/9.5 cm FIGO IIIB NA ACC+ large cell SCC Surgery + Radiation NED, 6 months
Mazur, M. T et al. [26] 76 Spotting No visible tumor/NA NA NA ACC + small foci of invasive SCC + CIS Surgery + Radiation NA
Miles, P. A et al. [27] NA NA NA NA NA 3 of 12 showed ACC+ invasive SCC NA NA
Hoskins, W. J et al. [28] 54 NA NA FIGO IB NA Adenosquamous carcinoma and the adeno
component is ACC
Surgery + Radiation NED, 12 months
Bittencourt, A. L et al. [29] 60 Bleeding Fragile mass/7 cm FIGO IB NA ACC + invasive SCC Surgery + Radiation NED, 9 months
72 Bleeding NA FIGO IB NA ACC + invasive SCC Radiation NED, 27 months
Tchertkoff and Sedlis [30] 63 Bleeding NA NA NA ACC + invasive SCC Surgery Metastasis 3 years later
live with disease
Fowler, W. C et al. [31] NA NA NA NA NA 1 of 9 patient showed ACC+ invasive SCC NA NA
Shingleton, H. M et al. [32] 78 Bleeding Fungated mass/NA FIGO III NA ACC+ focal SCC Radiation DOD, 3 months
65 Spotting NA FIGO IIB NA ACC+ focal SCC Surgery + Radiation NED
64 NA NA NA NA ACC+ poorly differentiated SCC Surgery + Radiation DOD, 5 months
Ramzy, I et al. [33] 68 Bleeding No visible tumor NA NA ACC + invasive SCC Surgery + Radiation DOD, 27 months










Because ACC is an aggressive form of cervical cancer
with a propensity for local recurrence and widespread
metastasis, the identification of ACC and the enhance-
ment of post-operative treatment regimens, including
radiation and chemotherapy, are critically important
and careful follow-up is recommended. However, the
number of the cases in our study was small, and the
clinical follow-up was limited; more cases are neces-
sary to further explore the histogenesis of ACC in the
uterine cervix.
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